KEZAR Trademark

Trademark Overview

On Friday, February 8, 2019, a trademark application was filed for KEZAR with the United States Patent and Trademark Office. The USPTO has given the KEZAR trademark a serial number of 79256294. The federal status of this trademark filing is REGISTERED as of Tuesday, December 15, 2020. This trademark is owned by KEZAR LIFE SCIENCES AUSTRALIA PTY LTD. The KEZAR trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating autoimmune diseases or cancer

pharmaceutical preparations for preventing or treating immune system related diseases and disorders; pharmaceutical products for preventing or treating cancer; chemical preparations for pharmaceutical preparations for treating autoimmune diseases or cancer

Medical research; biotechnology research; pharmaceutical research and development

General Information

Serial Number79256294
Word MarkKEZAR
Filing DateFriday, February 8, 2019
Status700 - REGISTERED
Status DateTuesday, December 15, 2020
Registration Number6218825
Registration DateTuesday, December 15, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements

Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating autoimmune diseases or cancer
Goods and Servicespharmaceutical preparations for preventing or treating immune system related diseases and disorders; pharmaceutical products for preventing or treating cancer; chemical preparations for pharmaceutical preparations for treating autoimmune diseases or cancer
Goods and ServicesMedical research; biotechnology research; pharmaceutical research and development

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, April 12, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 12, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKEZAR LIFE SCIENCES AUSTRALIA PTY LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameKEZAR LIFE SCIENCES AUSTRALIA PTY LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameKEZAR LIFE SCIENCES AUSTRALIA PTY LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Saturday, April 24, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 18, 2021GENERIC MADRID TRANSACTION SENT TO IB
Thursday, March 18, 2021GENERIC MADRID TRANSACTION CREATED
Monday, March 15, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, January 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 15, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, October 3, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 16, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 27, 2020EXPARTE APPEAL TERMINATED
Thursday, August 27, 2020EX PARTE APPEAL-REFUSAL REVERSED
Friday, June 5, 2020REPLY BRIEF FILED - CHECK TTAB FILES
Monday, May 4, 2020NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Monday, May 4, 2020EXAMINERS STATEMENT E-MAILED
Monday, May 4, 2020EXAMINERS STATEMENT - COMPLETED
Thursday, March 5, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 24, 2020EX PARTE APPEAL-INSTITUTED
Monday, February 24, 2020EXPARTE APPEAL RECEIVED AT TTAB
Friday, February 14, 2020NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Friday, February 14, 2020ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Friday, February 14, 2020ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Thursday, February 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, January 31, 2020NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Friday, January 31, 2020ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Friday, January 31, 2020ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Tuesday, January 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 18, 2019NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Wednesday, December 18, 2019ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Wednesday, December 18, 2019SUBSEQUENT FINAL REFUSAL WRITTEN
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 25, 2019NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Monday, November 25, 2019ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Monday, November 25, 2019ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 23, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 23, 2019FINAL REFUSAL E-MAILED
Monday, September 23, 2019FINAL REFUSAL WRITTEN
Friday, September 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 28, 2019REFUSAL PROCESSED BY IB
Friday, June 7, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 7, 2019REFUSAL PROCESSED BY MPU
Friday, May 17, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 16, 2019NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, April 23, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 22, 2019NON-FINAL ACTION WRITTEN
Sunday, April 21, 2019ASSIGNED TO EXAMINER
Tuesday, April 16, 2019APPLICATION FILING RECEIPT MAILED
Friday, April 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

kezar treating pharmaceutical diseases cancer research preparations autoimmune preventing chemical development